20 February 2020: Phase II clinical trial for Brain metastases in non-small cell lung cancer (NSCLC) approved by the Taiwan Food and Drug Administration (TFDA) 27 February 2020: Komipharm files for emergency clinical trial of its investigative drug to treat coronavirus pneumonia, which is...